Navigation Links
Vol in Medical Technology

Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer

...hase III randomized placebo-controlled Trial (SHARP trial), Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. vol 25, No. 18S (June 20 Supplement), 2007: LBA1 [2] Health Risks from Dioxin and Related Compounds, National Research Council, Natio...

AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds

...or Aurora B kinase. Aurora A and B have been shown to be over-expressed in a broad range of tumours. 4)Hung Huynh et al (2006),Clin Cancer Res;4309, vol 12 (14) July 15 ...

Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections

...2) Klevens, et al. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002. Public Health Reports, March-April 2007, vol 122, pp. 160-166. (3) Cardinal Health analysis of 3.1 million admissions across 100 hospitals, 2007. ...

Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds

... and strategic partners and other factors described in the Quest Diagnostics Incorporated 2007 Form 10-K and subsequent SEC filings. (1) THE LANCET, vol 361, March 1, 2003 (2) DIABETES CARE, VOLUME 31, NUMBER 4, APRIL 2008 ...

New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma

...utic as adjuvant therapy in stage IB/II Non-Small Cell Lung Cancer (NSCLC)' Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. vol 25, No. 18S (June 20 Supplement), 2007: 7554. (5) http://www.who.int/uv/faq/skincancer/en/index1.html (Date of access: May 6, 2008). (6) http...

Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency

...educed-intensity autologous stem cell transplantation in elderly patients with multiple myeloma: Results of a randomised IFM trial. The Lancet vol 370 October 6, 2007, pp 1209-1217 Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-lo...

AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer

... double-blind randomized phase II trial. Journal of Clinical Oncology, vol 24, No 18S, 2006: 7000. (2) Heymach JV et al. Randomized, Placebo-Controll...ously Treated Non-Small-Cell Lung Cancer Journal of Clinical Oncology, vol 25, No 27, 2007: 4270-4277. ...

Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks

...r haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)." The Lancet, vol 370, Pages 1415-1421. October 20, 2007 ...

Mircera Effective in Stabilising Haemoglobin Levels in Elderly Patients With Kidney Disease on Dialysis

...e Unites States Renal Data System 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. American Journal of Kidney Diseases. vol 45, No 1, Suppl 1, January 2005 (iv) European Best Practice Guidelines (v) United States Renal Data System, 2006 (vi) Obrador et al.,...

Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference

...uidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia," Am J Respir Crit Care Med, vol 171. pp. 388-416, 2005.) How often does it occur? According to the American Thoracic Society, the incidence of hospital acquired pneumonia is usua...

New Data Suggests Less Abuse-Related Effects For OROS Methylphenidate

...ce and Correlates of Adult ADHD in the United States: Results from the National Comorbidity Survey Replication." American Journal of Psychiatry. 2006. vol 163. Pg 724-732. CONTACT: On-Site Media Contacts, Ambre Morley of McNeil Pediatrics,Office, +1-609-730-3429, Cell, +1-908-507-0160, Christina Witz o...

New Data Focuses on Abuse of Stimulant Medication

...ce and Correlates of Adult ADHD in the United States: Results from the National Comorbidity Survey Replication." American Journal of Psychiatry. 2006. vol 163. Pg 724-732. ### Yael Goldberg DeVries Public Relations 30 East 60th Street New York, NY 10022 (P) 212.891.0456 (F) 212.644.0291 <...

Cogane Data Presented at ‘11th International Congress of Parkinson’s Disease and Disorders’

...administered orally to pre-clinical models of Parkinson's disease, Cogane(tm) reverses the loss of dopaminergic neurones. *Movement Disorders (2007) vol 22 (Suppl 16): page S18, abstract number 58. Parkinson's disease Parkinson's disease is a movement disorder characterised by muscle rigidity, trem...

New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

...g information or statements. 1. Samama.New England Journal of Medicine.Sept.1999. 2. Bergqvist New England Journal of Medicine March 2002/ vol 346, No.13. 3. Hull, Ann Intern Med.2001; 135:858-869. 4. Geerts.Chest.2004. CONTACT: Contact: Philippe BARQUET +33-6-70-48-61-28 Tick...
Other Tags
(Date:5/11/2015)... , May 11, 2015  Synaptics Incorporated (NASDAQ: ... interface solutions, today announced the appointment of ... Chief Financial Officer, reporting to Rick Bergman ... current Chief Financial Officer, Kathleen Bayless , ... Mr. Ali brings extensive financial management ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2
(Date:5/28/2015)... WA (PRWEB) May 28, 2015 Senior ... baseball legend Lou Piniella, who managed the Seattle Mariners ... 2001. Piniella will appear in television and digital advertising ... senior living apartment communities, including several new communities slated ... in Bellevue, Bothell, Lynnwood, Mountlake Terrace, Tukwila, and University ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Healthpointe ... will now be offering Echocardiography Examinations to patients ... performed by renowned Qualified Medical Examiner and licensed ... echocardiography test is a non-invasive and cost-effective approach ... are critically ill or have undergone surgery. ...
(Date:5/28/2015)... May 28, 2015 CompanionDx ... company, announces that it will present their integrated ... testing at the annual American Society of Clinical ... sequencing evaluates the DNA in a patient’s tumor ... analyzed for key changes or somatic mutations. Pharmacogenomics ...
(Date:5/28/2015)... Mass. (PRWEB) May 28, 2015 ... $17.5 million round of financing led by Cambia ... solutions company dedicated to transforming health care by creating ... largest and most utilized network for exchanging medical imaging, ... growing customer base, increase the breadth of its network ...
(Date:5/28/2015)... 28, 2015 The drug epidemic has struck ... article published on May 12th, 2015, by Bradenton , ... of time. The first victim, Dylan Besser (21) was a ... the scene. The second overdose victim, Julian Toomsen-Hall (18) was ... the alarming overdose deaths on campus, the college has created ...
Breaking Medicine News(10 mins):Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:Healthpointe Is Now Offering Echocardiography Examinations at the Anaheim Clinic. 2Health News:CompanionDx® Launches Integrated Genomic Solution at ASCO Meeting 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 3
Other Contents